INTERASMA scientific network (INES) is running a internet based survey on "beliefs and behaviours about biological treatments for severe asthma"

Dear colleagues, INTERASMA scientific network (INES) is running a  internet based survey on "beliefs and behaviours about biological  treatments for severe asthma" which you can access by clicking on the  following link:
The survey is anonymous however if you wish to leave your e-mail address you will be part of the communication activities and you will be invited to be part of the INES Network*
Fulvio Braido
INTERASMA Secretary General
* INESnet (Interasma Scientific nertwork) is a meeting place to get to know each other, to know who does what and where. The purpose is to create an international network, to work together, to offer opportunities. The values which underlie this project are the sharing of efforts, facilities, opportunities, thoughts and ideas with the aim to develop and spread a critical quantity of scientific products, favoring rapidity in full respect of scientific rigor. The drivers for all INESnet members should be to be part of a recognized scientific network and the achievement of benefits from cooperative working. The expected change is the increase of members' scientific expertise (CV- career) and the opportunity to grow from the professional point of you. INESnet was born as an editorial project on obstructive lung diseases. The starting working tool will be a dedicated digital platform for meeting, sharing, discussing, researching and writing papers. This will allow to start a tight collaboration characterized by mindedness, fluency, speed, productivity on a broad field of issues in obstructive lung diseases.
-- Fulvio Braido, MD
Associate Professor of Respiratory Medicine
University of Genoa
Respiratory Diseases and Allergy Clinic
Ospedale Policlinico San Martino 
Pad.Maragliano - L.R. Benzi 10 - 16132 - Genova (IT)
e-mail: This email address is being protected from spambots. You need JavaScript enabled to view it.

(You must be logged in to add and reply comments)

Interasma on Twitter

Interasma Top story: FDA to Review BLA for Oral Immunotherapy AR101 for Peanut Allergy - Pulmonology Advisor…
Interasma RT @Aller_MD: “VIDEO: #Dupilumab or cyclosporine for treating atopic dermatitis?”
Interasma RT @Aller_MD: “More than one in five infants with a bronchiolitis hospital admission will have a subsequent respiratory-related hospital ad…
Interasma RT @Aller_MD: “FDA to Review BLA for Oral Immunotherapy AR101 for Peanut #Allergy
Interasma RT @Aller_MD: 10 startups tackling the problem of high prescription drug costs. Managing payments, connecting consumers to reimbursement op…

Editor: Juan C. Ivancevich, MD

Copyright © Interasma 2003-2017  •  Terms of Use  •  Privacy Policy  •  Contact Us  •  Sitemap

Powered by FREI SA